Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
No association seen for overall PFAS mixture, but higher midlife weight seen per doubling of PFOS, 2-(N-ethyl-perfluorooctane sulfonamido) acetate
Read More »Specific PFAS Differentially Affect Maternal Midlife Adiposity
Skin Care Product Use by Children Tied to Phthalates/Replacement Metabolites
SCP use associated with urinary phthalate/replacement metabolites among young children
Read More »High Insulin Levels Genetically Linked to Lower Lipoprotein(a)
Authors say inverse association may be explained by hyperinsulinemia
Read More »SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
Findings show greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors
Read More »Interleukin-6 May Boost Prediction of Obesity-Related Cancers
Findings seen among patients with newly diagnosed type 2 diabetes
Read More »Chronic Diabetes Complications Bidirectionally Linked to Mental Health Disorders
Findings seen across the life span and irrespective of diabetes type
Read More »Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price
By Ernie Mundell HealthDay ReporterTUESDAY, Aug. 27, 2024 (HealthDay News) — Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.The new 2.5 milligram (mg) and 5 mg weekly dose …
Read More »FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 Diabetes
Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks
Read More »Meat Consumption Linked to Increased Incidence of Type 2 Diabetes
Risk increased in association with consumption of 100 g/day red meat, 50 g/day processed meat
Read More »Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM
Estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults
Read More »